Rocky Mountain Life Science Investor Conference Announces Final 13 Presenting Companies and Nationally Acclaimed Speakers

Share Article

Organizers of the Inaugural Rocky Mountain Life Science Investor Conference (RMLIC) have announced the final 13 of 30 presenting companies that will showcase their innovations to leading investors and industry experts on September 17 at the Ritz Carlton, Denver. In addition to finalizing the presenting company roster, the RMLIC also released details regarding nationally acclaimed speakers for the event: Nobel Laureate Dr. Tom Cech and Roy Davis, President J&J Corporate Development.

Organizers of the Inaugural Rocky Mountain Life Science Investor Conference (RMLIC) have announced the final 13 of 30 presenting companies that will showcase their innovations to leading investors and industry experts on September 17 at the Ritz Carlton, Denver. The announcement is made by John Collar, President & CEO of the Colorado BioScience Association (CBSA), who says the conference itinerary will also feature nationally acclaimed speakers Nobel Laureate Dr. Tom Cech and Roy Davis, President J&J Corporate Development.

"Both the Colorado BioScience Association and the Arizona BioIndustry Association along with our regional partners are simply thrilled to have both Roy Davis and Dr. Cech present during the Rocky Mountain Life Science Investor Conference," Collar explains. "This will provide an opportunity for attendees to hear from two leaders within the industry and show the excitement around the biosciences that lie within the Rocky Mountain region."

The final 13 of the 30 presenting companies at the RMLIC include:

  • Allogenesis - Denver, CO - Website coming soon
  • Applied Microarrays, Inc. - Tempe, AZ - appliedmicroarrays.com
  • Axial Biotech - Salt Lake City, UT - axialbiotech.com
  • Beacon Biotechnology - Aurora, CO - beaconbiotechnology.com
  • Castle Biosciences- Phoenix, AZ - castlebiosciences.com
  • Leap Frogg - Grand Junction, CO - Website coming soon
  • LigoCyte Pharmaceuticals - Bozeman, MT - ligocyte.com
  • Medipacs - Tucson, AZ - medipacs.com
  • NanoMR - Albuquerque, NM - nanomr.com
  • Numira Biosciences - Salt Lake City, UT - numirabio.com
  • PharmaJet - Golden, CO - pharmajet.com
  • SenesTech, Inc. - Flagstaff, AZ - senestech.com
  • Western States Biopharmaceuticals - Aurora, CO - westernstatesbiopharm.com

Last month, during the first-round of the RMLIC selection process, the following 17 companies were announced: Apoplogic, Aurora, CO; BioAmps, Aurora, CO; Biodesix, Broomfield, CO; BiOptix Diagnostics, Boulder, CO; Coherex, Salt Lake City, UT; GlobeImmune, Louisville, CO; High Throughput Genomics, Tucson, AZ; Inviragen, Fort Collins, CO; Kinetic Muscles, Tempe, AZ; LineaGen, Salt Lake City, UT; Medivance, Louisville, CO; miRagen, Boulder, CO; Myocept, Lafayette, CO; Regenesis, Scottsdale, AZ; ThermImage, Salt Lake City, UT; ValveXchange, Aurora, CO; and Vital Access, Salt Lake City, UT.

More about the inaugural RMLIC

The conference will commence with a breakfast keynote presentation by Roy Davis who will lend his insight behind the world of biosciences and his expectations for the bioscience industry and what lies ahead for Johnson & Johnson. He will also delve into the world of partnerships and the importance of attending conferences and networking to build relationships and collaboration within the industry.

Over the last year, the State of Colorado has been anticipating Dr. Tom Cech's return to the University of Colorado Boulder and the implementation of the new Colorado Initiative for Molecular Biology (CIMB). Dr. Cech will provide the luncheon keynote presentation during the RMILC and give the audience a preview into his research and what the future holds. The CIMB will be opening its doors in December of 2011, and during Dr. Cech's presentation he will be able to discuss the collaboration and innovation that will generate from this unique project.

In addition to the two keynote presentations, the RMLIC will showcase two panel discussions during the day. The first panel, will be moderated by Dr. Patrick Mahaffy, President and CEO of Clovis Oncology. The second panel will consist of venture capital leaders from across the nation to provide advice and lessons learned to the participants at the RMLIC.

For registration information, visit the conference website at http://www.rmlic.com.

About Arizona BioIndustry Association

The Arizona BioIndustry Association is a not-for-profit, 501(c)(6) trade association that seeks to unify, empower and advance its member organizations, allowing them to benefit individually by acting collectively. AZBio strives to enhance the environment that makes Arizona a place where bioscience companies can grow and succeed. AZBio is the state affiliate in Arizona for the Biotechnology Industry Organization (BIO), the preeminent trade association for the biotechnology industry in the United States. For more information, visit http://www.azbio.org.

About Colorado BioScience Association

CBSA is a not-for-profit corporation providing services and support for Colorado's growing biosciences industry. With more than 400 members, the CBSA actively works to promote the growth of the industry by advocating for a better business environment, by promoting programs that grow the state's bioscience workforce, by fighting for policies that support a strong bioscience industry in the state and by speaking with a single voice on behalf of the companies in the state. For more information, visit http://www.cobioscience.com.

Contacts:

April Giles, Vice President, Administration & Operations, Colorado BioScience Association, 303-592-4071

Leah Kientz, Director of Public Policy and Programs, Colorado BioScience Association - 303-592-4088

Maggie Chamberlin Holben, APR, Absolutely PR - http://www.absolutelypr.com - 303-984-9801

###

Share article on social media or email:

View article via:

Pdf Print

Media

Rocky Mountain Life Science Investor ConferenceOrganizers of the Inaugural Rocky Mountain Life Science Investor Conference (RMLIC) have announced the final 13 of 30 presenting companies that will showcase their innovations to leading investors and industry experts on September 17 at the Ritz Carlton, Denver. In addition to finalizing the presenting company roster, the RMLIC also released details regarding nationally acclaimed speakers for the event: Nobel Laureate Dr. Tom Cech and Roy Davis, President J&J Corporate Development. For registration information, visit the conference website at http://www.rmlic.com. Dr. Tom CechOver the last year, the State of Colorado has been anticipating Dr. Tom Cech’s return to the University of Colorado Boulder and the implementation of the new Colorado Initiative for Molecular Biology (CIMB). Dr. Cech will provide the luncheon keynote presentation during the RMILC and give the audience a preview into his research and what the future holds. The CIMB will be opening its doors in December of 2011, and during Dr. Cech’s presentation he will be able to discuss the collaboration and innovation that will generate from this unique project. In addition to the two keynote presentations, the RMLIC will showcase two panel discussions during the day. The first panel, will be moderated by Dr. Patrick Mahaffy, President and CEO of Clovis Oncology. The second panel will consist of venture capital leaders from across the nation to provide advice and lessons learned to the participants at the RMLIC.Roy DavisThe conference will commence with a breakfast keynote presentation by Roy Davis who will lend his insight behind the world of biosciences and his expectations for the bioscience industry and what lies ahead for Johnson & Johnson. He will also delve into the world of partnerships and the importance of attending conferences and networking to build relationships and collaboration within the industry.